Nachrichten zur Catalyst Pharmaceuticals Inc. Aktie

Form 8-K CATALYST PHARMACEUTICALS For: Jun 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Catalyst Pharmaceuticals Reports Positive Momentum in Second Quarter 2023

Reaffirms Full Year 2023 Total Revenue Guidance of Between $375 Million and $385 Million...…

Down 19% in 1 Day, Is Catalyst Pharmaceuticals a Smart Contrarian Buy?

When evaluating investments, it helps to keep quarterly performance in context....…

Insiderhandel: President and CEO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 345.978$

Mcenany, Patrick J. - Vorstand - Tag der Transaktion: 2023-05-15...…

Zacks.com featured highlights include Catalyst Pharmaceuticals, Warby Parker, MakeMyTrip Ltd., Brookfield Renewable Partners & Century Aluminum

Catalyst Pharmaceuticals, Warby Parker, MakeMyTrip Ltd., Brookfield Renewable Partners & Century Aluminum are part of the Zacks Screen of the…

Implied Volatility Surging for Catalyst Pharmaceuticals (CPRX) Stock Options

Investors need to pay close attention to Catalyst Pharmaceuticals (CPRX) stock based on the movements in the options market lately....…

Catalyst Pharmaceuticals: Q1 Earnings Insights

Form 8-K CATALYST PHARMACEUTICALS For: May 10

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Catalyst Pharmaceuticals Reports Record First Quarter 2023 Results, Achieving 98% Total Revenue Growth Year-over-Year

CORAL GABLES, Fla., May 10, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst or the Company") (Nasdaq: CPRX) today…

Catalyst Pharmaceuticals Advances sNDA Submission Plans To Increase Indicated Maximum Dose For FIRDAPSE® From 80 mg Per Day To 100 mg Per Day

Concluded Positive FDA Type-C Meeting in Early May 2023...…

Catalyst Pharmaceuticals Announces Release of Inaugural ESG Report

CORAL GABLES, Fla., May 01, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage biopharmaceutical…

Catalyst Pharmaceutical (CPRX) Outpaces Stock Market Gains: What You Should Know

Catalyst Pharmaceutical (CPRX) closed at $16.52 in the latest trading session, marking a +0.24% move from the prior day....…

Catalyst Pharmaceuticals Announces Third-Party Abstracts on FYCOMPA® (Perampanel) to be Presented at the Upcoming American Academy of Neurology 2023 Annual Meeting

CORAL GABLES, Fla., April 20, 2023 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric…

Catalyst Pharmaceutical (CPRX) Stock Sinks As Market Gains: What You Should Know

Catalyst Pharmaceutical (CPRX) closed the most recent trading day at $17.82, moving -1.44% from the previous trading session....…

Catalyst Pharmaceutical (CPRX) Flat As Market Sinks: What You Should Know

Catalyst Pharmaceutical (CPRX) closed the most recent trading day at $17.55, making no change from the previous trading session....…

Zacks Industry Outlook Highlights Catalyst Pharmaceuticals, KalVista Pharmaceuticals, Larimar Therapeutics, Nektar Therapeutics and Jounce Therapeutics

Catalyst Pharmaceuticals, KalVista Pharmaceuticals, Larimar Therapeutics, Nektar Therapeutics and Jounce Therapeutics are part of the Zacks Industry Outlook article....…

Form 8-K/A CATALYST PHARMACEUTICALS For: Jan 24

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Aufsichtsrat verkauft Aktien von Catalyst Pharmaceuticals im Wert von 504.900$

Tierney, David S. - Aufsichtsrat - Tag der Transaktion: 2023-04-05...…

Here is What to Know Beyond Why Catalyst Pharmaceuticals, Inc. (CPRX) is a Trending Stock

Catalyst (CPRX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware…

Insiderhandel: VP, Treasurer and CFO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 962.786$

Grande, Alicia - Vorstand - Tag der Transaktion: 2023-03-28...…

Insiderhandel: VP, Treasurer and CFO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 835.100$

Grande, Alicia - Vorstand - Tag der Transaktion: 2023-03-29...…

Insiderhandel: Chief Commercial Officer verkauft Aktien von Catalyst Pharmaceuticals im Wert von 667.810$

Del, Carmen Jeffrey - Vorstand - Tag der Transaktion: 2023-03-29...…

Catalyst Pharmaceutical (CPRX) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Catalyst Pharmaceutical (CPRX) closed at $16.44, marking a +1.99% move from the previous day....…

Insiderhandel: VP, Treasurer and CFO verkauft Aktien von Catalyst Pharmaceuticals im Wert von 689.528$

Grande, Alicia - Vorstand - Tag der Transaktion: 2023-03-22...…

Zacks.com featured highlights include Catalyst Pharmaceuticals, Terex and Arista Networks

Catalyst Pharmaceuticals, Terex and Arista Networks are part of the Zacks Screen of the Week article....…

Catalyst Pharmaceutical (CPRX) Gains But Lags Market: What You Should Know

Catalyst Pharmaceutical (CPRX) closed at $16.53 in the latest trading session, marking a +0.79% move from the prior day....…

3 Stocks With Solid Earnings Growth to Buy Right Away

Invest in stocks like Catalyst Pharmaceuticals (CPRX), Terex (TEX) & Arista Networks (ANET) at the moment for superb earnings growth....…

Form 8-K CATALYST PHARMACEUTICALS For: Mar 15

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Catalyst Pharmaceuticals Non-GAAP EPS of $0.31 beats by $0.11, revenue of $60.76M beats by $0.12M

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Catalyst Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Achieved Record 2022 Total Net Revenues of $214 Million, a 52% YoY Increase...…

Earnings Outlook For Catalyst Pharmaceuticals

Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth

Catalyst (CPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report.…

Form 8-K CATALYST PHARMACEUTICALS For: Mar 01

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Zacks.com featured highlights Lamb Weston, Catalyst Pharmaceuticals and Northeast Community Bank

Lamb Weston, Catalyst Pharmaceuticals and Northeast Community Bank have been highlighted in this Screen of The Week article....…

Catalyst Pharmaceutical (CPRX) Outpaces Stock Market Gains: What You Should Know

Catalyst Pharmaceutical (CPRX) closed the most recent trading day at $15.38, moving +0.79% from the previous trading session....…

Catalyst Pharmaceuticals, Inc. (CPRX) Is a Trending Stock: Facts to Know Before Betting on It

Recently, Zacks.com users have been paying close attention to Catalyst (CPRX). This makes it worthwhile to examine what the stock…

Catalyst Pharmaceuticals to Ring the Nasdaq Closing Bell in Honor of International Rare Disease Day

Spotlight On Raising Awareness for Rare Diseases on February 28, 2023...…

Investors Heavily Search Catalyst Pharmaceuticals, Inc. (CPRX): Here is What You Need to Know

Zacks.com users have recently been watching Catalyst (CPRX) quite a bit. Thus, it is worth knowing the facts that could…

Form 8-K CATALYST PHARMACEUTICALS For: Feb 07

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Catalyst Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2022 Total Revenues and Provides Full Year 2023 Revenue Guidance

2022 Total Revenues Estimated at $214 Million, Representing 52% YoY Growth...…

dpa-AFX ProFeed